Podcasts

Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

Long Term Survivorship: Thriving with Metastatic Lung Cancer

Episode Summary

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

This TOGA Podcast focuses on thriving with lung cancer and overcoming the challenges associated with long term survivorship and lung cancer. The past decade has seen significant advances in the management of metastatic NSCLC with the advent of multiple targeted therapies, immunotherapy approaches and combination approaches and associated improvements in survival outcomes for patients. There is an emerging cohort of patients with advanced NSCLC who experience long periods of disease control whilst on these treatments.

Traditionally survivorship has referred to the care of or issues for patients following curative treatment of early-stage disease. However, due to the recent advances described here, there is a compelling need to begin addressing the issues faced by long term metastatic disease ’survivors’.

Show Hosts

This episode’s host are:

  • Lillian Leigh, Membership and Advocacy Chair, TOGA; long-term survivor of lung cancer
  • Dr Sarah Heynemann, Medical Oncologist
  • Mary Duffy, Lung Cancer Clinical Nurse Consultant, Lung MDT, Peter MacCallum Cancer Institute

Play Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

More Podcasts

In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.